Introduction
Chronic heart failure (CHF) is a major public health problem. Currently, more than 15 million patients have heart failure in North America and Europe, with nearly 1.5 million new cases every year. 1, 2 Heart failure is the most frequent cause of hospitalization among people older than 65 years of age, and these hospitalizations account for the enormous cost of the disease. 3, 4 A number of prior studies showed positive effects of exercise training on exercise capacity, quality of life and biomarkers, observing relatively few complications during training in CHF patients. [5] [6] [7] Two recent metaanalyses and a randomized-controlled trial suggested improved survival and decreased hospitalizations for CHF patients undergoing exercise training as compared with a nonexercising control group. [8] [9] [10] In 2006, the Italian National System for Guidelines of the Italian Health Ministry published the Guidelines on Cardiac Rehabilitation and Secondary Prevention, with the endorsement of the Italian Agency of Regional Health Systems. 11 Although the adherence to Guidelines has been shown to be associated with improved outcomes, their current implementation in Italy, as in other European countries, remains frequently defective. [12] [13] [14] [15] [16] In the recent past, the Italian Association for Cardiovascular Prevention and Rehabilitation [Gruppo Italiano di Cardiologia Riabilitativa (GICR)-IACPR] promoted and carried out a detailed observational study of cardiac Original article rehabilitation programs available in Italy. 17 The broad participation of cardiac rehabilitation centers throughout Italy and the dimension of surveyed population proved to represent the real, pragmatic rehabilitation world and to describe the clinical profile of patients referred to cardiac rehabilitation programs.
As a considerable part of this study cohort consisted of CHF patients, the present survey aimed at providing an insight into the clinical characteristics and course of a CHF population in the real world of cardiac rehabilitation in Italy.
Methods

Study design
The multicenter, prospective observational study design of the Italian SurveY on carDiac rEhabilitation (ISYDE-2008) has been described in detail elsewhere. 14, 17 In summary, the primary purpose of the ISYDE-2008 study was to take a snapshot of the current organization, settings and provision of cardiac rehabilitation in Italy and to describe the patient population referred to cardiac rehabilitation, giving a comprehensive and detailed description of clinical characteristics, risk profile, diagnostic procedures, exercise and educational program, discharge modalities, treatment at discharge and follow-up schedules. The enrollment period lasted from 28 January to 10 February 2008. Data were collected on a web-based Case Report Form, which collected data on clinical characteristics, diagnostic procedures, exercise and educational programs, treatment and follow-up plans of all the consecutive patients discharged from cardiac rehabilitation programs in the 2-week study period. The present study focuses on patients entering cardiac rehabilitation with an admitting diagnosis of CHF. Cognitive function was evaluated by Mini-Mental State Evaluation (MMSE), 18 and cognitive impairment was assigned when corrected MMSE value was less than 21.
Participating centers
The survey was designed to be carried out in all Italian residential or outpatient cardiac rehabilitation centers. Centers were invited to participate in the survey on a purely voluntary basis by the executive board of the study and by the regional GICR-IACPR coordinator, who was responsible for interfacing with the investigators in each of the participating centers and overlooked the implementation of the survey protocol. On the basis of information collected from previous surveys and registries and through an active search of National Health System authorized facilities carried out at regional level, 208 facilities were identified as potential providers of cardiac rehabilitation programs and were invited to participate in the study. However, 18 centers were found to be inactive or still in a preoperational phase at the time of the study, whereas 25 (13% of the remaining 190) were unwilling or unable to participate. Thus, data collected in the study refer to 165 cardiac rehabilitation units (87% of all invited facilities). Role of the funding source No funding sources had any role in the study design, conduction, data collection, analysis, data interpretation or writing of this report. The GICR-IACPR coordinated the study, managed the data and undertook all analyses. All members of the scientific board and writing committees had full access to the database and assumed final responsibility for the results submitted for publication.
Statistical analysis
The main analysis was performed subdividing the study cohort into two groups, according to the diagnosis of CHF. Data are expressed as means AE SD or proportions. Comparisons between groups were performed by unpaired t test, x 2 or Fisher exact test as required. Correlations between variables were assessed with Pearson's correlation coefficient. Predictors of death were evaluated with multivariate logistic regression analysis. All analyses were performed using SAS (Version 9.1, SAS Institute Inc., Cary, North Carolina, USA) with significance set at P < 0.05.
Results
The entire ISYDE study cohort consisted of 2281 patients (66.9 AE 11.8 years): 285 CHF patients (age 71.3 AE 12.2 years, 66% male) and 1996 non-CHF patients (age 66.3 AE 11.6 years, 74% male). Table 1 summarizes the demographic and risk profile characteristics of the study population. Patients were subdivided in a low, medium or high-risk score according to the number of cardiovascular risk factors present. CHF patients showed a significantly higher cardiovascular risk factor score (including smoking, history, hypertension, dyslipidemia, obesity, diabetes, sedentary lifestyle and early menopause) compared with non-CHF patients (P ¼ 0.04). Compared with non-CHF, CHF patients showed a greater frequency of comorbidities such as previous acute myocardial infarction (AMI), percutaneous coronary intervention (PCI), cardiac surgery, peripheral artery disease (PAD), chronic obstructive pulmonary disease (COPD), cognitive impairment, cancer and orthopedic/ joints/immune-related diseases ( Table 2) .
During cardiac rehabilitation programs, a higher percentage of CHF patients developed complications such as severe ventricular arrhythmias and acute kidney disease or worsening of chronic kidney disease (CKD), and required inotropic support or respiratory assistance: these were also the more frequent complications during the cardiac rehabilitation program, apart from anemia and atrial fibrillation, which, however, were equally observed in CHF and non-CHF patients (Table 3) .
Differences between CHF and non-CHF patients were also detected in the access to diagnostic procedures and interventions during cardiac rehabilitation. Compared with non-CHF, CHF patients more likely underwent diagnostic procedures such as 6-minute walking test (6MWT) and cardiopulmonary stress testing on admission or at discharge (Table 4) . However, as many as 75 CHF patients (26%) received no physical performance test (6MWT, exercise stress testing or cardiopulmonary exercise testing); this proportion was significantly greater than in non-CHF patients (20%, P < 0.0001). Compared with non-CHF not performing any physical performance testing (20% of the non-CHF cohort), CHF patients not performing any physical performance testing (26% of the CHF cohort) showed a higher percentage of coexisting comorbidities such as previous AMI (32 versus 17%, P ¼ 0.002), PAD (15 versus 6%, P ¼ 0.004), COPD (24 versus 14%, P ¼ 0.03), CKD (33 versus 13%, P < 0.0001), cancer (11 versus 3%, P ¼ 0.003), and orthopedic disease (24 versus 14%, P ¼ 0.03), or previous interventions such as cardiac surgery (24 versus 9%, P ¼ 0.0001) or PCI (14 versus 5%, P ¼ 0.003), respectively; these patients also showed a higher percentage of complications during the cardiac rehabilitation program such as severe ventricular arrhythmias (11 versus 1%, P < 0.0001) and kidney failure (17 versus 5%, P ¼ 0.0002). Finally, not undergoing any physical performance test Cardiac rehabilitation in heart failure Giallauria et al. 157 Table 2 Comorbidity in patients admitted to cardiac rehabilitation program (n, %) was a significant predictor of death during cardiac rehabilitation in CHF patients [odds ratio (OR) 7.0, 95% confidence interval (CI), 1.9-25.8,
Echocardiography showed a lower percentage of CHF patients with preserved left ventricular ejection fraction (LVEF >50%), compared with non-CHF patients (23 versus 73%, P < 0.0001, respectively); and a higher percentage of moderate (LVEF ¼ 30-49%, 47 versus 24%, P < 0.0001, respectively) and severe (LVEF < 30%, 30%, 30 versus 3%, P < 0.0001, respectively) LV systolic dysfunction.
Compared with non-CHF, CHF patients were more frequently discharged on angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin II receptor blockers (ARB), nitrates, diuretics, oral anticoagulant therapy, digitalis, amiodarone, insulin and heparin, and less frequently on statin and aspirin (Table 5) . No significant changes were observed in b-blocker prescription (Table 5) .
CHF patients had a significantly longer hospital length of stay (20 AE 13 versus 18 AE 10 days, P ¼ 0.003), less daily access to hospital daycare (13 AE 11 versus 16 AE 9 days, P ¼ 0.04), were less likely to be discharged home (85 versus 92%, P < 0.0001), and rather more likely transferred to ICU (9 versus 3%, P < 0.0001) compared with non-CHF patients, respectively. CHF patients had a higher death rate during cardiac rehabilitation programs (1.7 versus 0.5%, P ¼ 0.01). After adjusting for age, ejection fraction, preexisting comorbidities or previous interventions (AMI, PCI, cardiac surgery, carotid artery critical lesions, PAD, COPD, CKD, stroke, cognitive impairment), complications during the cardiac rehabilitation program (atrial fibrillation, severe ventricular arrhythmias, acute respiratory insufficiency and acute renal failure or worsening of CKD) and not performing any physical performance testing (6MWT, exercise stress testing or cardiopulmonary exercise testing), multivariate logistic analysis showed that acute respiratory insufficiency (OR 2.3, 95% CI, 1.3-4.1, P ¼ 0.002), acute kidney insufficiency or worsening of CKD (OR 2.9, 95% CI, 1.5-5.6, P ¼ 0.001), worsening of cognitive impairment (OR 3.7, 95% CI, 2.0-6.7, P < 0.001), severe ventricular CHF, chronic heart failure. arrhythmias (OR 9.8, 95% CI, , P ¼ 0.005), and not performing any of the physical performance tests (OR 7.0, 95% CI, 1.9-25.8, P ¼ 0.003) were significant predictors of death in CHF patients.
Discussion
The present study, by deriving data from the 2008 ISYDE survey, is the first to explore in such depth the characteristics of the 'real world' CHF patients admitted to cardiac rehabilitation programs in Italy.
Although exercise-based cardiac rehabilitation is recognized as an essential component in the contemporary management of patients with CHF, including the elderly, admission to cardiac rehabilitation and secondary prevention programs of patients with CHF is far from optimal. [14] [15] [16] The present survey revealed that only 12.5% of patients admitted to cardiac rehabilitation had a diagnosis of CHF. These patients were older, more frequently men and with more severe comorbidities, thus, closely reflecting the real world of patients with CHF presenting in the acute ward. As expected, we found higher mean age in CHF patients (127 out of 285 CHF patients were !75 years old), as the increased severity and complexity of cardiac disease in older patients, associated with higher frequency of comorbidities (particularly COPD and renal insufficiency) may easily lead to CHF and precipitate an acute episode of heart failure. 19 In line with previous findings, 20 this survey confirmed in CHF patients the large burden of comorbidities (previous coronary event and revascularizations, CKD, COPD, diabetes, cancer and orthopedic diseases) explaining the higher frequency of complications occurring during cardiac rehabilitation in this patient population.
In particular, CHF patients participating to cardiac rehabilitation programs had a higher prevalence of COPD compared with non-CHF patients (14 versus 3.6%, P < 0.0001). Concomitant COPD has an important impact on mortality and hospitalization rates as well as on quality of life in patients with CHF. 21 Multiple common mechanisms may explain this negative prognostic association, such as exercise-induced increase in functional residual capacity, 22 COPD induced hemoglobin desaturation hypocapnia or further worsening of right-ventricular function, 23 or activation of inflammatory mechanisms. 24 In fact, in the present survey, COPD strongly increases the burden of care in patients with heart failure: the association of COPD with CHF was likely responsible for the higher frequency of respiratory assistance in CHF (4.6 versus 1.4%, P ¼ 0.0002); and, in addition, acute respiratory insufficiency was a significant predictor of death in CHF patients during cardiac rehabilitation (OR 2.3, 95% CI, 1.3-4.1, P ¼ 0.002).
This survey also highlighted the higher prevalence of diabetes in CHF patients participating in cardiac rehabilitation programs, compared with non-CHF patients (33 versus 19%, P < 0.0001, respectively). Diabetes mellitus is indeed a well-known risk factor for heart failure. Even after adjustment for concomitant risk factors, diabetic patients have an almost two-fold increased risk of heart failure. 25 Previous data showed that the prevalence of concomitant diabetes mellitus in patients with heart failure varies from 19 to 31%. 26 The strong association between diabetes mellitus and heart failure is partly explained by the high prevalence of ischemic heart disease, hypertension and obesity in diabetic patients. The associated increase in advanced glycosylation end products, endothelial dysfunction, increased circulating free fatty acids, a preferential shift in myocardial metabolism toward less efficient fatty acid oxidation, and a proinflammatory state may all contribute to the development of myocardial dysfunction, reduced exercise tolerance and heart failure. 27 Compared with the non-CHF cohort, CHF patients also showed a higher prevalence of CKD (24.2 versus 6.6%, P < 0.0001), and acute kidney failure or worsening of CKD was a significant predictor of death in CHF patients during cardiac rehabilitation programs (OR 2.9, 95% CI, 1.5-5.6, P ¼ 0.001). Renal dysfunction is a common feature in CHF patients and the definition of 'cardiorenal syndrome' is used to describe the concomitant presence of renal and cardiac dysfunction. 28 Renal dysfunction and heart failure share some comorbidity such as hypertension, diabetes and CAD, which confer a significantly increased risk of developing both conditions. They also share common pathophysiological mechanisms, including neurohormonal and inflammatory activation; in addition, several drugs frequently used in CHF patients, such as diuretics, ACE-I or ARBs might impair kidney function in CHF patients and lead to acute renal function deterioration. 29 Therefore, these observations suggest the need to monitor renal function closely in patients with CHD during the cardiac rehabilitation protocol.
The present survey showed that the diagnosis of cognitive impairment was significantly more frequent in CHF patients as compared to the non-CHF cohort, a likely consequence of the more advanced age of our CHF population. Cognitive dysfunction and heart failure are commonly associated conditions in the elderly. 30, 31 On the contrary, previous studies showed that the risk of cognitive impairment is increased in CHF patients, as compared to the general population, independently of age of the patient. 30, 31 Potential underlying mechanisms for cognitive dysfunction in heart failure may involve low cardiac output status with consequent cerebral hypoperfusion as well an intrinsic increased risk of cerebrovascular ischemic events. 30, 31 Therefore, these findings suggest that an initial evaluation of cognitive performance should be implemented in CHF patients admitted to cardiac rehabilitation. Of note, worsening of cognitive impairment was a significant predictor of death in the CHF cohort.
Compared with the non-CHF cohort, functional evaluation tests such as 6MWT and cardiopulmonary exercise stress test were more frequently performed in CHF patients, the former as a submaximal test in patients not capable of exercising on a cycle or treadmill, the second in a small proportion of less functionally compromised patients. However, compared with non-CHF, a larger proportion of CHF patients did not perform cycle or treadmill exercise stress test or any type of physical performance test at all (26 versus 20%, P < 0.0001). Interestingly, not performing any physical performance testing was a significant predictor of death in CHF patients (OR 7.0, 95% CI, 1.9-25.8, P ¼ 0.003). These findings might reflect a more compromised cardiovascular status preventing CHF patients from performing exercise stress testing, or might be due to the more frequent comorbidities with relative contraindication to exercise (COPD, orthopedic-joints disease etc.).
The present survey also revealed interesting differences in prescription of drugs at discharge. CHF patients were discharged from Cardiac Rehabilitation Units with fewer indications to statins, compared with the non-CHF cohort, thus, confirming the difficulties of adopting in the real clinical world and in CHF patients the recommendations of international guidelines regarding secondary prevention. 15 As expected, CHF patients received at discharge more frequent prescriptions of ACE-I, ARBs, digitalis and nitrates. Amiodarone and insulin were more prescribed for supraventricular or ventricular arrhythmias and diabetes, respectively. The low aspirin prescription was, at least in part, a reflection of the increased combined prescription of oral anticoagulants and heparin.
Finally, mortality during the performance of cardiac rehabilitation program was higher in CHF patients compared wit the non-CHF cohort (1.7 versus 0.5%, P ¼ 0.01), reflecting the higher clinical risk profile of these patients. Unfortunately, we do not have a control group of patients with CHF not entering in cardiac rehabilitation to adequately evaluate the significance of this finding. However, the mortality in the first months following hospital discharge of CHF patients not enrolled in cardiac rehabilitation protocols is likely to be even higher than that observed in our study. 32 
Study limitations
The number of patients with CHF reported in the present survey is very small (about 12% of the overall population). This makes the study underpowered for a deepened interpretation. This probably depends on the very small time of the enrollment period (only 2 weeks). The combination of data from cardiac rehabilitation centers offering very different cardiac rehabilitation regimens (e.g. residential versus outpatients) is another confounder. The observational nature of the study cannot rule out that the more severely compromised patients with CHF were not addressed to cardiac rehabilitation, and therefore those described in our study may represent a selected, more relatively healthy minority. However, this survey successfully highlighted crucial differences in the clinical characteristics, risk profile, management and short-term outcome in a CHF patient population entering cardiac rehabilitation programs in Italy, compared with non-CHF patients. Another putative limitation of the present study was the lack of reporting some important functional and clinical parameters of possible interest; this was due to the short-term survey characteristics of the study, which collected the essential data in order to characterize the demographic and clinical course of the patients. Finally, according to recent evidence, [33] [34] [35] the present survey did not collect data regarding modality of exercise training regimen (interval versus continuous) or the dose of exercise (in terms of volume and intensity) which can greatly affect the functional and clinical parameters (together with outcome) of CHF patients.
In conclusion, this survey shows in a large population the characteristics of the clinical risk profile, resource utilization, pharmacologic treatment and course of cardiac rehabilitation programs in CHF patients entering cardiac rehabilitation programs in Italy. Future studies are needed in order to identify the best strategies for expanding referral to cardiac rehabilitation of CHF patients, particularly of those more compromised, and fostering the application of tailored functional evaluation, educational intervention, optimization of pharmacological and nonpharmacological treatment, and adherence to secondary prevention guidelines, with the aim of reducing in-hospital complications and improving functional recovery, long-term mortality, morbidity and quality of life of these high-risk patients.
